Clinical isolates of ST131 bla OXA-244-positive Escherichia coli, Italy, December 2022 to July 2023
- PMID: 38390649
- PMCID: PMC10899817
- DOI: 10.2807/1560-7917.ES.2024.29.8.2400073
Clinical isolates of ST131 bla OXA-244-positive Escherichia coli, Italy, December 2022 to July 2023
Abstract
The dissemination of carbapenemase-producing Escherichia coli, although still at low level, should be continuously monitored. OXA-244 is emerging in Europe, mainly in E. coli. In Italy, this carbapenemase was reported from an environmental river sample in 2019. We report clinical isolates of OXA-244-producing ST131 E. coli in four patients admitted to an acute care hospital in Pavia, Italy. The association of this difficult-to-detect determinant with a globally circulating high-risk clone, ST131 E. coli, is of clinical relevance.
Keywords: Escherichia coli; OXA-244; ST131; WGS; high-risk clone; surveillance.
Conflict of interest statement
Figures
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical